Health Care · Services-Home Health Care Services · Nasdaq · CIK 1725255 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $10.68Day −1.02%Mkt cap $1.5B1Y +17.0%Off 52W high −20.5%Vol (1Y) 47.2%
Daily closing price, split-adjusted to the current basis; 3y shown of 2,040 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Price impliesHEROIC · 26.1% growth |
| Short interest5.9% of sh out |
| Days to cover7.4d |
| 13F net flow (QoQ)+3.29% |
| Top-10 13F concentration65.3% |
| Next report (est.)2026-08-04 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$3.29B |
| Earnings (TTM)-$79.6M |
| ROE−4.6% |
| Net margin−2.2% |
| Debt / equity1.14× |
| Total debt / EBITDA3.67× |
| YTD+7.2% |
| 1Y+17.0% |
| 3Y−22.3% |
| 5Y−52.3% |
| Since incept. (ann.)+1.2% |
Total return through 2026-07-30 · series begins 2018-05-24. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)47.2% |
| Ann. volatility (3Y)58.4% |
| Sharpe (1Y)0.52 |
| Sharpe (3Y)0.14 |
| Max drawdown (1Y)−28.8% |
| Max drawdown (3Y)−56.1% |
| Beta (3Y vs SPY)1.08 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| OEP CAPITAL ADVISORS, L.P. | 16.3M | $194M | 12.00% | +18.1% |
| BlackRock, Inc. | 15.9M | $190M | 11.73% | +1.6% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 11.5M | $137M | 8.44% | +0.0% |
| REINHART PARTNERS, LLC. | 10.1M | $120M | 7.42% | +24.5% |
| SkyKnight Capital, L.P. | 8.6M | $102M | 6.31% | +0.0% |
| FMR LLC | 8.1M | $96M | 5.93% | +5.5% |
| DIMENSIONAL FUND ADVISORS LP | 6.9M | $82M | 5.09% | +8.1% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6.1M | $73M | 4.49% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. Institutional 13F holdings sum to 103.9% of shares outstanding. Readings above 100% reflect securities-lending double counting: shares on loan to short sellers are reported long by both the lending institution and the one that bought them. FINRA short interest of 7,968,266 shares (settlement 2026-04-30) accounts for the excess.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-05 | −$0.12 | — | $819.8M | +5.4% |
| 2025-12-31 | 2026-02-24 | — | — | $846.3M | −1.2% |
| 2025-09-30 | 2025-11-04 | $0.16 | +6.7% | $820.3M | +1.8% |
| 2025-06-30 | 2025-08-05 | $0.10 | −23.1% | $800.4M | −0.7% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-04 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Sleep Health 42% · Respiratory Health 21% · Diabetes Health 18% · Wellness At Home 18%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| Sales growth 3Y3.0% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
